Risk of Stroke After Transcatheter Aortic Valve Implantation: Epidemiology, Mechanism, and Management
Conclusions:
The overall evidences confirm similar or lower rate of stroke in TAVI versus SAVR. Risk predictors for acute stroke after TAVI are generally related to procedural factors, whereas late stroke is mainly associated with patient characteristics, with a variable impact on cognitive function. The optimal choice for the antithrombotic treatment in TAVI for stroke prevention is yet to be determined. Current data do not support routine use of cerebral embolic protection devices during TAVI.
Source: American Journal of Therapeutics - Category: Drugs & Pharmacology Tags: Therapeutic Advances Source Type: research
More News: Accidents | Anatomy | Aortic Stenosis | Clinical Trials | Disability | Drugs & Pharmacology | Epidemiology | Heart Valve Surgery | Ischemic Stroke | Stroke | Thrombosis